Literature DB >> 19694176

Sensitive high performance liquid chromatographic assay for nitazoxanide metabolite in plasma.

M I Ruiz-Olmedo1, J L Gallegos-Perez, K G Calderon-Gonzalez, J Franco-Perez, H Jung-Cook.   

Abstract

A sensible and specific HPLC analytical method for the determination of tizoxanide (TZO), the active metabolite of nitazoxanide (NTZ) in rat plasma was developed and validated. Samples of 200 microL were efficiently deproteinized with acetonitrile. Assay was performed using a C18 CC with a ternary gradient elution of 50 mmol x L(-1) KH2PO4 : acetonitrile : methanol and UV/Vis detection at 416 nm. The analytical method was linear in a range of 10-1280 ng x mL(-1), precise (RSD % > 2.2), accurate (RE % < 7.8) and with high recovery (% > 95%). Stability studies showed that TZO was stable in plasma for short and long-time period (45 days) and proved to be suitable for pharmacokinetic studies of NTZ in rats. The method was also evaluated using human plasma samples and no statistical differences were found in the response-curve between rat and human samples.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19694176

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

1.  Validated stability indicating methods for determination of nitazoxanide in presence of its degradation products.

Authors:  Nouruddin W Ali; Samah Sayed Abbas; Hala El-Sayed Zaazaa; Maha Mohamed Abdelrahman; Mohamed Abdelkawy
Journal:  J Pharm Anal       Date:  2011-11-30

2.  Effect of nitazoxanide on albendazole pharmacokinetics in cerebrospinal fluid and plasma in rats.

Authors:  María Isabel Ruiz-Olmedo; Iliana González-Hernández; Francisca Palomares-Alonso; Javier Franco-Pérez; María de Lourdes González F; Helgi Jung-Cook
Journal:  Saudi Pharm J       Date:  2016-09-30       Impact factor: 4.330

3.  Quantitation of tizoxanide in multiple matrices to support cell culture, animal and human research.

Authors:  Megan Neary; Usman Arshad; Lee Tatham; Henry Pertinez; Helen Box; Rajith Kr Rajoli; Anthony Valentijn; Joanne Sharp; Steve P Rannard; Giancarlo A Biagini; Paul Curley; Andrew Owen
Journal:  bioRxiv       Date:  2021-05-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.